Zinc influx promotes mitophagy to slow intervertebral disc degeneration
Targeting the zinc transporter ZIP14 and ANXA2 deacetylation restores autophagic flux and limits degenerative spinal disease in experimental models.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) · Jin Y et al. · Paper published 27 Sep 2026
In cellular and in vivo models of intervertebral disc degeneration, researchers investigated how senescence-related ion imbalances suppress autophagy. By combining single-cell RNA sequencing, messenger RNA sequencing, and mass spectrometry, the team identified the zinc transporter ZIP14 as a central regulatory factor. They found that intracellular zinc drives the deacetylation of annexin A2 at lysine 302. In vitro mutagenesis and molecular dynamics simulations showed that this deacetylation alters the annexin A2-mTOR complex and prevents annexin A2 from binding mTOR, thereby restoring mitophagy. Acetylated annexin A2 accumulated abnormally during disease development and restrained mitophagy. In vivo experiments confirmed that ZIP14 sustains this protective signaling, and dietary zinc supplementation effectively slowed disc degeneration.
Why it matters
Disrupted ion balance and defective mitochondrial clearance are central features of cellular senescence and tissue aging. Connecting zinc transport directly to mTOR-dependent mitophagy reveals a potential metabolic mechanism for preserving spinal tissue with age.
Caveats
The abstract does not specify the animal species tested in vivo, so translational relevance to humans remains unconfirmed. Further work is needed to evaluate the therapeutic efficacy and safety of dietary zinc in human patients.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Persistent Zn²⁺ Influx-Mediated Deacetylation of ANXA2 Regulates the "Zn²⁺-Autophagic Flux" and Alleviates Intervertebral Disc Degeneration
Jin Y, Chen Y, Xie Y et al.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 27 Sep 2026 · Peer-reviewed
- Relevance
- Relevant
- News value
- Notable
- Evidence
- Cells
- Status
- Peer-reviewed
More on Mitochondria
See allCardiolipin loss drives muscle fiber shifts during aging via a nuclear receptor
Restoring cardiolipin synthesis in knockout mice reversed muscle atrophy and prevented premature death.
Nature aging · Finger F et al.
Early-life mitochondrial DNA mutations drive age-related pathology in mice
Manipulating mitochondrial fusion can alter tissue-specific selection against deleterious variants that arise early in development.
bioRxiv · Shemtov SJ et al.
Inhibiting miR-128-3p restores muscle mass and function in aged mice
The microRNA inhibitor also improved cardiac outcomes after infarction and reduced pathology in mouse and pig models of muscular dystrophy.
bioRxiv : the preprint server for biology · Boldridge MA et al.
Prodh2 inhibition alleviates muscle atrophy and restores strength in COPD mice
TNF-alpha triggers a mitochondrial immune pathway via Prodh2 that damages myoblasts, while silencing the enzyme restores muscle strength in mice.
Aging cell · Chen G et al.
Depp1 drives muscle loss under fasting and low oxygen in mice
The study reveals that the protein localizes to mitochondria to regulate autophagy and mitochondrial degradation during nutrient and oxygen limitation.
bioRxiv · Qayyum S et al.